Senior Associate Consultant
Mayo Clinic
Rochester, Minnesota, United States
Dr. Meng Xu Welliver, MD, PhD is a translational radiation oncologist whose clinical expertise encompasses soft tissue sarcoma, lymphoma, and thoracic malignancies. She leads multidisciplinary efforts to advance precision radiotherapy and improve outcomes for patients with rare and aggressive tumors.
Dr. Welliver’s research bridges laboratory discovery and clinical translation, focusing on the intersection of DNA damage response (DDR) signaling, tumor immunology, and radiotherapy. Her work integrates preclinical modeling with early-phase clinical trial design to develop biomarker-driven strategies that exploit DDR vulnerabilities and enhance therapeutic synergy with advanced radiation techniques.
At Mayo Clinic in Rochester, Dr. Welliver serves as the Sarcoma Disease Group Lead for Radiotherapy, guiding both clinical care and translational research initiatives. Nationally, she is active in multiple cooperative oncology groups and professional societies, contributing to the design of innovative trials and educational programs that shape the future of radiation oncology.
Saturday, November 15, 2025
11:00 AM - 12:00 PM EST
Disclosure information not submitted.
